Tag Archive for: Genetic mutation

In addition to becoming a Nasdaq-listed company, the focus of Elicio moving forward will be a therapeutic cancer vaccine candidate that targets mKRAS-driven tumors.

If approved, the treatment, branded Hemgenix, will be the first gene therapy in the European Union for the condition that is usually treated by regular injections of factor IX, the European Medicines Agency said.

Mirati Therapeutics Inc.’s experimental drug that targets a specific genetic mutation helped about one third of a small subset of patients in a clinical trial whose lung cancer had spread to their brains, the company said on Monday.